The global urology robotic surgery market size reached US$ 1.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 10.5% during 2023-2028. The increasing prevalence of bone degenerative and kidney or urinary tract diseases, especially amongst the geriatric population, along with the rising demand for minimally invasive assisted surgeries for knee and hip replacements, represent some of the key factors driving the market.
Urology robotic surgery is a minimally invasive treatment that includes miniaturized computer-controlled manipulators and surgical instruments with a video camera and artificial sensing solutions. These devices are placed in small punctures instead of large incisions by various robotic consoles under the supervision of healthcare professionals to reach distant and critical spaces and view highly magnified and clear three-dimensional (3D) pictures of the area to be operated. It encompasses robotic machines, navigation systems, simulators, planners, and other crucial accessories as standard equipment types. Urology robotic surgery offers accurate motions and increased magnification, maximizes productivity, ensures peer collaborations during treatment procedures, and minimizes recovery time, blood loss, and post-surgical complications. Apart from this, it reduces scarring, pain, discomfort, and the risk of infection ensures shorter hospitalization and provides better clinical outcomes. As a result, urology robotic surgeries are extensively utilized in hospitals and clinics for prostatectomy, cystectomy, nephrectomy, and pyeloplasty surgical procedures.
Urology Robotic Surgery Market Trends:
The increasing prevalence of kidney or urinary tract diseases represents one of the key factors driving the market growth. The increasing geriatric population, which is susceptible to such ailments, is also contributing to the market growth. In line with this, the rising demand for minimally invasive assisted surgeries for knee and hip replacements, due to their multiple benefits over traditional surgical procedures, is acting as another growth-inducing factor. Additionally, the rising need for automated surgical tools that significantly reduce the chances of human errors is driving the market toward growth. Moreover, the integration of robot-assisted flexible endoscopes with the system that enables healthcare practitioners to access and treat complex anatomies and enhance precision in diagnostic proceedings is favoring the market growth. Furthermore, the advent of the software-enforced remote center of motion (RCM) and modular robotic surgical systems with complex motion control capability is impelling the market growth. Apart from this, the ongoing research and development (R&D) activities to manufacture urology surgical robots with enhanced efficacy and the fueling number of product diversification for surgical interventions are creating a positive outlook for the market. Other factors, such as increasing healthcare budgets and improving healthcare infrastructure, are driving the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global urology robotic surgery market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on component and application.
- Robotic Surgery Systems
- Instruments and Accessories
The report has also provided a detailed breakup and analysis of urology robotic surgery market based on the component. This includes robotic surgery systems, instruments and accessories and services. According to the report, instruments and accessories represented the largest segment.
- Robotic Prostatectomy
- Robotic Cystectomy
- Robotic Pyeloplasty
- Robotic Nephrectomy
A detailed breakup and analysis of the urology robotic surgery market based on the application has also been provided in the report. This includes robotic prostatectomy, robotic cystectomy, robotic pyeloplasty, robotic nephrectomy and others. According to the report, robotic prostatectomy accounted for the largest market share.
- North America
- Asia Pacific
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for urology robotic surgery. Some of the factors driving the North America urology robotic surgery market included the increasing prevalence of kidney and urinary tract diseases and the rising geriatric population.
The report has also provided a comprehensive analysis of the competitive landscape in the global urology robotic surgery market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Intuitive Surgical Inc., Johnson & Johnson, Medtronic plc, Stryker Corporation, Surgical Science Sweden AB, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
|Base Year of the Analysis
| Historical Period
||Component, Application, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Intuitive Surgical Inc., Johnson & Johnson, Medtronic plc, Stryker Corporation, Surgical Science Sweden AB, etc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Benefits for Stakeholders:
- IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the urology robotic surgery market from 2017-2028.
- The research study provides the latest information on the market drivers, challenges, and opportunities in the global urology robotic surgery market.
- The study maps the leading as well as the fastest growing regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the urology robotic surgery industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.